Benchmark Maintains Buy on Clene, Lowers Price Target to $31
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Bruce D. Jackson maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $33 to $31.
Benchmark analyst Bruce D. Jackson maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $33 to $31.